STAT+: Medical pioneers team up to launch new cell therapy biotech

Medical pioneers Carl June, Bruce Levine, and Drew Weissman have teamed up to launch a new biotech that hopes to use the industry’s buzziest technologies to boost the beleaguered cell therapy field.

Their new venture, Capstan Therapeutics, launched Wednesday with a combined $165 million in seed and Series A financing.

Continue to STAT+ to read the full story…